Durvalumab Intravenous and Hyaluronidase Subcutaneous, Injection
Determining the interaction of Durvalumab Intravenous and Hyaluronidase Subcutaneous, Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: durvalumab
Brand name: Imfinzi
Synonyms: Durvalumab
Generic Name: hyaluronidase
Brand name: Amphadase, Hylenex, Vitrase, Wydase, Hydase
Synonyms: Hyaluronidase, Hyaluronidase (injection)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Durvalumab Intravenous-Hyate:C
- Durvalumab Intravenous-Hybrisil
- Durvalumab Intravenous-Hycamtin
- Durvalumab Intravenous-Hycamtin (Topotecan Capsules)
- Durvalumab Intravenous-Hycamtin (Topotecan Injection)
- Durvalumab Intravenous-Hycamtin Capsules
- Hyaluronidase Subcutaneous, Injection-Dutasteride
- Hyaluronidase Subcutaneous, Injection-Dutasteride and tamsulosin
- Hyaluronidase Subcutaneous, Injection-Dutasteride and Tamsulosin Capsules
- Hyaluronidase Subcutaneous, Injection-Dutasteride Capsules
- Hyaluronidase Subcutaneous, Injection-Dutoprol
- Hyaluronidase Subcutaneous, Injection-Duvelisib